Cross-matching TB and AIDS registries: TB patients with HIV co- infection, United States, 1993-1994

Public Health Reports

Volumn 114, Issue 3, 1999, Pages 269-277

  Moore, Marisa ^a   McCray, Eugene ^b   Onorato, Ida M ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ARTICLE; COMORBIDITY; DEMOGRAPHY; DISEASE ASSOCIATION; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REGISTER; TUBERCULOSIS; UNITED STATES;

EID: 0033064092     PISSN: 00333549     EISSN: None     Source Type: Journal    
DOI: 10.1093/phr/114.3.269     Document Type: Article

References (25)

1. Burwen DR, Bloch AB, Griffin LD, Ciesielski CA, Stern HA, Onorato IM. National trends in the concurrence of tuberculosis and acquired immunodeficiency syndrome. Arch Intern Med 1995;155:1281-6.
2. Shafer RW, Edlin BR. Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis 1996;22:683-704.
3. Cantwell MF, Snider DE, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994;272:535-9.
4. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41 (RR-17):1-19.
5. Bloch AB, Onorato IM, Ihle WM, Hadler JL, Hayden CH, Snider DE. Expanded tuberculosis surveillance in the United States: the need for epidemic intelligence. Public Health Rep 1996;111:26-31.
6. Centers for Disease Control and Prevention (US). Reported tuberculosis in the United States, 1993. Atlanta: CDC; 1994 Oct.
7. Centers for Disease Control and Prevention (US). Reported tuberculosis in the United States, 1994. Atlanta: CDC; 1995 Jul.
8. Co-incidence of HIV/AIDS and tuberculosis - Chicago, 1982-1993. MMWR Morb Mortal Wkly Rep 1995;44:227-31.
9. Surveillance of tuberculosis and AIDS co-morbidity - Florida, 1981-1993. MMWR Morb Mortal Wkly Rep 1996;45:38-41.
10. Rieder HL, Cauthen GM, Bloch AB, Cole CH, Holtzman D, Snider DE, et al. Tuberculosis and acquired immunodeficiency syndrome - Florida. Arch Intern Med 1989;149:1268-73.
11. Centers for Disease Control and Prevention (US). Reported tuberculosis in the United States, 1997. Atlanta: CDC; 1998 Jul.
12. Jones JL, Burwen DR, Fleming PL, Ward JW. Tuberculosis among AIDS patients in the United States, 1993. J Acquir Immune Defic Syndr 1996;12:293-7.
13. Barnes PF, Bloch AB, Davidson PT, Snider DE. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991;324:1664-50.
14. Moore M, Onorato IM, McCray E, Castro KG. Trends in drug-resistant tuberculosis in the United States, 1993-1996. JAMA 1997;278:833-7.
15. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, et al. The epidemiology of tuberculosis in San Francisco. N Engl J Med 1994;330:1703-9.
16. Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, et al. Transmission of tuberculosis in New York City. N Engl J Med 1994;330:1710-16.
17. Frieden TB, Fujiwara PI, Washko RY, Hamburg MA. Tuberculosis in New York City - turning the tide. N Engl J Med 1995;333:229-33.
18. Small PM, Shafer RW, Hopewell PC, Singh SP, Murphy MJ, Desmond E, et al. Exogenous reinfection with multidrug-resistant Mycobocterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993;328:1137-44.
19. Nolan CM, Williams DL, Cave MD, Eisenach KD, El-Hajj H, Hooton TM, et al. Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis. Am J Respir Crit Care Med 1995;152:1067-71.
20. Bradford WZ, Martin JN, Reingold AL, Schecter GF, Hopewell PC, Small PM, et al. The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA. Lancet 1996;348:928-31.
21. Whitney CG, Ridzon R, Paul W. Epidemiology of rifampin-resistant tuberculosis (RRTB), Chicago [abstract]. In: Abstracts: 1996 International Conference; May 10-15; New Orleans; American Thoracic Society. Am J Respir Crit Care Med 1996;153:A492.
22. Ridzon R, Whitney CG, McKenna MT, Taylor JP, Ashkar SH, Nitta AT, et al. Risk factors for rifampin mono-resistant tuberculosis. Am J Respir Crit Care Med 1998;157:1881-4.
23. Lutfey M, Della-Latta P, Kapur V, Palumbo LA, Gurner D, Stotzky G, et al. Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS. Am J Respir Crit Care Med 1996;153:837-40.
24. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR Morb Mortal Wkly Rep 1998;47(RR-20):1-58.
25. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1997;46(RR-12):10-12.